Discover the promises and limitations of peptide-based vaccines for the treatment of prostate cancer, in this commentary article from Future Science OA
Browsing: Taxonomy > Immunotherapy
NGS-guided assessment of interactions between tumors and the immune system leads to new discoveries in immuno-oncology. Introduction Traditionally the…
Data has demonstrated that a novel immunotherapy is generally well tolerated and exhibits preliminary evidence of anti-tumor activity in hepatocellular carcinoma patients.
The European Commission has recently approved dinutuximab beta for high risk neuroblastoma patients over the age of 12 months, making it the only approved immunotherapy in Europe for this group of patients.
Did you attend the 2nd Annual Advances in Immuno-Oncology Congress this year? In this conference report find out more about the successes of the event and find out how you can attend the event next year.
Find out in this perspective article how cytotoxic and expanded NK cells induced in cancer patients may be turned into pathogenic factors if they enter immune-privileged microenvironments in susceptible individuals.
In this research article from Immunotherapy find out about a somatic cell reprogramming procedure which may provide a novel and effective means to treat malignancies.
Oncology Central is hosting a free 2-day online educational symposium, chaired by Professor Angus Dalgleish (St George’s, University of London) aimed at delivering oncology professionals key updates in this field. This online symposium will be CME-accredited.